Literature DB >> 6855814

Determinants of survival in patients with ventricular tachyarrhythmias.

C D Swerdlow, R A Winkle, J W Mason.   

Abstract

We analyzed data from 239 patients with sustained ventricular tachycardia or ventricular fibrillation to determine prognosis, predictors of survival, and the prognostic value of inducing arrhythmia and assessing therapy at the time of electrophysiologic study. Therapy predicted to be effective on the basis of electrophysiologic study was administered over a sustained period. There were 71 cardiac deaths, including 44 sudden deaths, during a mean (+/- S.D.) follow-up period of 14.8 +/- 13.9 months (range, one day to 67 months). At one, two, and three years, the actuarial incidence of sudden death was 17 +/- 3, 25 +/- 4, and 34 +/- 6 per cent, and that of cardiac death was 28 +/- 3, 37 +/- 4, and 50 +/- 6 per cent. Multivariate regression analyses demonstrated that the two strongest predictors of both sudden death and cardiac death were a higher New York Heart Association functional class (P less than 0.0001 for sudden death and P less than 0.0001 for cardiac death) and the failure of any therapy to be identified as potentially effective on the basis of electrophysiologic study (P = 0.0019 and P = 0.0003). The majority of deaths in patients with ventricular tachyarrhythmias were sudden, but the severity of heart failure was the strongest independent predictor of mortality. Response to therapy during electrophysiologic study was also an independent predictor of survival.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6855814     DOI: 10.1056/NEJM198306163082402

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  34 in total

Review 1.  Diagnosis and management of ventricular tachycardia.

Authors:  M Dancy
Journal:  Postgrad Med J       Date:  1992-06       Impact factor: 2.401

2.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

3.  Electrophysiologic evaluation of antiarrhythmic drugs.

Authors:  P Touboul
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 4.  Amiodarone: maximising survival benefit with empiric or guided therapy.

Authors:  G Steinbeck; U Dorwarth; E Hoffmann
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 5.  Interaction between ventricular loading and repolarisation: relevance to arrhythmogenesis.

Authors:  P Taggart; P Sutton; M Lab
Journal:  Br Heart J       Date:  1992-03

6.  Hemodynamic effects of amiodarone during acute and chronic treatment in patients with recurrent sustained ventricular tachycardia.

Authors:  M Manz; W Jung; B Lüderitz
Journal:  Clin Investig       Date:  1992-05

7.  Exercise in electrocardiography.

Authors:  M R O'grady; B Carley; D G Allen
Journal:  Can Vet J       Date:  1991-02       Impact factor: 1.008

8.  Clinical experience with the transvenous Medtronic Pacer Cardioverter Defibrillator (PCD) System.

Authors:  A Golino; C Pappone; A Panza; M Santomauro; D Iorio; V De Amicis; M Chiariello; N Spampinato
Journal:  Tex Heart Inst J       Date:  1993

9.  Treatment of malignant ventricular arrhythmias with the automatic implantable cardioverter defibrillator.

Authors:  A D Slater; I Singer; C S Stavens; C Zee-Cheng; B L Ganzel; J Kupersmith; C Mavroudis; L A Gray
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

10.  Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs.

Authors:  A C Rankin; S Zaim; A Powell; B Zaim; R Brooks; B A McGovern; H Garan; J N Ruskin
Journal:  Br Heart J       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.